Suchergebnisse - (Person:"Guo, Ensong")

PubPharm (67)

11

The Trans-omics Landscape of COVID-19

enthalten in: ResearchSquare.com | 2022

von Wu, P. | Chen, D. | Ding, W. | +67

12

The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer

enthalten in: Microbial ecology | 2022

von Wang, Z. | Xiao, R. | Huang, J. | +8

13

Method, device and equipment for monitoring drug resistance of PARP inhibitor and medium

enthalten in: Europäisches Patentamt | 2022

von SUN CHAOYANG | CHEN GANG | HU DIANXING | +2

14

Spatial Heterogeneity of Infiltrating T cells in High-Grade Serous Ovarian Cancer revealed by Multi-omics analysis

enthalten in: ResearchSquare.com | 2022

von Sun, C. | Yang, B. | Li, X. | +21

15

AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway

enthalten in: Cancer letters | 2022

von Liu, C. | Huang, Y. | Qin, T. | +23

16

WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway

enthalten in: The Journal of experimental medicine | 2022

von Guo, E. | Xiao, R. | Wu, Y. | +18

17

Mutation profiles in circulating cell‐free DNA predict acquired resistance to olaparib in high‐grade serous ovarian carcinoma

enthalten in: Cancer Science | 2022

von Hu, D. | Guo, E. | Yang, B. | +18

18

Serum semaphorin 4C as a diagnostic biomarker in breast cancer : A multicenter retrospective study

enthalten in: Cancer communications (London, England) | 2021

von Wang, Y. | Qiao, L. | Yang, J. | +35

19

Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors

enthalten in: Aging | 2021

von Qin, T. | Guo, E. | Lu, F. | +17

20

WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade

enthalten in: Cancer science | 2021

von Wu, X. | Kang, X. | Zhang, X. | +12